PI
ICPT

PEAK6 Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

PEAK6 Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,000
Closed -$315K – 4944
2020
Q1 		$315K Buy
+5,000
New +$449K ﹤0.01% 2457

Other funds holding ICPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PEAK6 Investments's ICPT Position: Q3 2023 in Review

PEAK6 Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 3,644 shares — an estimated $40.3K sold.

PEAK6 Investments first reported a position in ICPT in Q3 2018 and held it in 5 quarters. The position peaked at $114K in Q1 2023. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • PEAK6 Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 3,644 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $40.3K.
  • PEAK6 Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 5 quarters.
  • PEAK6 Investments's Intercept Pharmaceuticals, Inc. position peaked at $114K in Q1 2023.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.